Obesity, Employment, and Economic Productivity in Europe: A Systematic Literature Review

Validation of the Obesity Lifecycle Model Built to Assess the Cost Effectiveness of Novel Therapies in the Management of Obesity

Development of Cardiovascular Risk Equations in People with Overweight or Obesity and Established Cardiovascular Disease Without Diabetes Based on the SELECT Trial

Addressing the risk of ocular complications of GLP-1RAs; a multi-disciplinary expert consensus

The evolving burden of obesity in the US: a novel population-level system dynamics approach

NHS 10 year plan: Can using AI offer a solution to the NHS’ problems?

The Composite Number Needed to Treat for Semaglutide in Populations with Overweight or Obesity and Established Cardiovascular Disease Without Diabetes

Cost-effectiveness of semaglutide in people with obesity and cardiovascular disease without diabetes

Disutility of injectable therapies in obesity and type 2 diabetes mellitus: general population preferences in the UK, Canada, and China

External validation of the core obesity model to assess the cost-effectiveness of weight management interventions

Adverse changes in HbA1c, body weight and insulin use in people with type 1 diabetes mellitus following dapagliflozin discontinuation in the DEPICT clinical trial programme